TipRanks
Go Ultimate55% OFF

Compare Ovid Therapeutics (1OT) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1OTOvid TherapeuticsEUR 2.24EUR 444.17M-5.2988.24%Strong BuyUnlock the DE:1OT analyst price target with TipRanks PremiumDE:1OTUnlock the DE:1OT top-analyst price target with TipRanks Premium
IRDOpus Genetics$3.64$305.33M-2.8960.87%Strong BuyUnlock the IRD analyst price target with TipRanks PremiumDE:1OT vs IRDUnlock the IRD top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.88$185.56M-0.8023.33%Strong BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:1OT vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
IKTInhibikase Therapeutics$1.51$216.28M-3.264.76%Strong BuyUnlock the IKT analyst price target with TipRanks PremiumDE:1OT vs IKTUnlock the IKT top-analyst price target with TipRanks Premium
SRZNSurrozen$28.27$341.32M-0.71107.29%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:1OT vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
BMEABiomea Fusion$0.63$46.35M-1.29-51.54%Strong BuyUnlock the BMEA analyst price target with TipRanks PremiumDE:1OT vs BMEAUnlock the BMEA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1OTOvid Therapeutics2.241.0893.10%
IRDOpus Genetics3.701.5672.90%
ZNTLZentalis Pharmaceuticals1.850.4128.47%
IKTInhibikase Therapeutics1.54-0.06-3.75%
SRZNSurrozen29.0215.96122.21%
BMEABiomea Fusion0.66-0.66-50.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts